Instrument Inactif

Autres langues Vexim

Actions

ALVXM

FR0011072602

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

VEXIM: +17% Growth in Sales in 2017 up to €21.6 Million	12/01/18
VEXIM : Announces the Results of the Simplified Tender Offer Initiated by Stryker	12/12/17
NASS 2017: VEXIM Cancels the Investor & Analyst Lunch Meeting and Webcast Scheduled on Wednesday, October 25th	25/10/17
VEXIM : to be Acquired by Stryker Corporation	24/10/17
VEXIM: Strong First Half 2017 Results, in Line with Expectations	14/09/17
VEXIM: Amendment of the Financial Agenda for 2017	13/09/17
VEXIM: Continued Growth and Adoption of the SpineJack® in Q2 2017	11/07/17
VEXIM: ANVISA Approves SpineJack® Implants in Brazil	29/05/17
VEXIM : in Facts, Five Years after the Stock Market Listing on the Alternext Market	17/05/17
Vexim : New Product Launch in Germany	03/05/17
Vexim : Continued sales growth in Q1 2017	03/05/17
VEXIM: Continued Sales Growth in Q1 2017	19/04/17
VEXIM: New Product Launch in Germany: MASTERFLOW™ PLUS, a New Product Targeted at Low Energy Osteoporotic Fractures	18/04/17
2016: A Historic Year for VEXIM	22/03/17
VEXIM: Another Major Step Towards the SpineJack® Commercialization in the US	21/02/17
VEXIM : strengthens its intellectual property protection for the SpineJack® in Asia	02/02/17
VEXIM Strengthens Its Intellectual Property Protection for the SpineJack® in Asia: Two Patents Granted in China and Japan	02/02/17
Vexim: Amendment of the Financial Agenda for 2017	30/01/17
VEXIM : Strengthens its Management Team, Through the Appointment of Russell Powers as Vice President and General Manager for its US Business	19/01/17
VEXIM : Sets New Sales Record in the 4th Quarter 2016 and Solidifies Its Position as a Major Player in Spine Trauma	17/01/17

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Vexim

Actions

ALVXM

FR0011072602

Autres langues

Filtres